Michael Kunst

Mr. Kunst became Chief Strategy Officer for Vectura Fertin Pharma in March 2023. He had previously been PMI’s Senior Vice President, Commercialization since November 2021, and before that had been Senior Vice President, Commercial Transformation since January 2019.

Prior to joining PMI, he was a Senior Partner at Bain & Company since 2009, leading Bain’s Healthcare Practice in EMEA and working with healthcare clients on growth strategy, commercial capability building, change management, and organizational effectiveness. From 1998 to 2009, he was a partner at Monitor Company, focusing on healthcare clients. He served as Head of Planning and Reporting at Arcor from 1996 to 1998. Mr. Kunst holds a Master’s in Business Administration from the European Business School in Oestrich-Winkel in Germany.

Mr. Kunst is a member of the Vectura Fertin Pharma Leadership Team, responsible for its business strategy and roadmap. In addition, he is also a member of the PMI Senior Management Team, supporting the strategic alignment and connection across the two organizations.